MTOR is a Key Modulator of Ageing and Age-related Disease

Overview

Journal Nature

Specialty Science

Date 2013 Jan 18

PMID 23325216

Citations 863

Authors

Simon C Johnson

Peter S Rabinovitch

Matt Kaeberlein

Affiliations

Soon will be listed here.

Abstract

Many experts in the biology of ageing believe that pharmacological interventions to slow ageing are a matter of 'when' rather than 'if'. A leading target for such interventions is the nutrient response pathway defined by the mechanistic target of rapamycin (mTOR). Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age-related pathologies. Characterized inhibitors of this pathway are already clinically approved, and others are under development. Although adverse side effects currently preclude use in otherwise healthy individuals, drugs that target the mTOR pathway could one day become widely used to slow ageing and reduce age-related pathologies in humans.

Citing Articles

RBIS as a prognostic biomarker for progression-free survival in prostate cancer: insights from bioinformatics and immune infiltration analysis.

Chen Z, Fang Y, Zhang J Discov Oncol. 2025; 16(1):297.

PMID: 40069535 PMC: 11896948. DOI: 10.1007/s12672-025-02083-4.

Citrulline regulates macrophage metabolism and inflammation to counter aging in mice.

Xie Z, Lin M, Xing B, Wang H, Zhang H, Cai Z Sci Adv. 2025; 11(10):eads4957.

PMID: 40053596 PMC: 11887811. DOI: 10.1126/sciadv.ads4957.

Correlation between physiological and biochemical variables during short term adequate protein intake combined with resistance exercise in sedentary adults.

Baek K, Won J, Kim C, Park J Sci Rep. 2025; 15(1):5459.

PMID: 39953174 PMC: 11828950. DOI: 10.1038/s41598-025-89925-x.

Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project.

Coleman A, Creevy K, Anderson R, Reed M, Fajt V, Aicher K Geroscience. 2025; .

PMID: 39951177 DOI: 10.1007/s11357-024-01484-7.

Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2.

Buttari B, Tramutola A, Rojo A, Chondrogianni N, Saha S, Berry A Biomolecules. 2025; 15(1).

PMID: 39858508 PMC: 11764413. DOI: 10.3390/biom15010113.

References

Mair W, Morantte I, Rodrigues A, Manning G, Montminy M, Shaw R . Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature. 2011; 470(7334):404-8. PMC: 3098900. DOI: 10.1038/nature09706. View

Onken B, Driscoll M . Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One. 2010; 5(1):e8758. PMC: 2807458. DOI: 10.1371/journal.pone.0008758. View

Singh-Manoux A, Kivimaki M, Glymour M, Elbaz A, Berr C, Ebmeier K . Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012; 344:d7622. PMC: 3281313. DOI: 10.1136/bmj.d7622. View

Lieberthal W, Levine J . Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications. Am J Physiol Renal Physiol. 2012; 303(2):F180-91. DOI: 10.1152/ajprenal.00015.2012. View

Kenyon C . The genetics of ageing. Nature. 2010; 464(7288):504-12. DOI: 10.1038/nature08980. View

Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View

Thoreen C, Chantranupong L, Keys H, Wang T, Gray N, Sabatini D . A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 2012; 485(7396):109-13. PMC: 3347774. DOI: 10.1038/nature11083. View

Kaeberlein M, Powers 3rd R, Steffen K, Westman E, Hu D, Dang N . Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005; 310(5751):1193-6. DOI: 10.1126/science.1115535. View

Spilman P, Podlutskaya N, Hart M, Debnath J, Gorostiza O, Bredesen D . Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One. 2010; 5(4):e9979. PMC: 2848616. DOI: 10.1371/journal.pone.0009979. View

10.

Kapahi P, Zid B, Harper T, Koslover D, Sapin V, Benzer S . Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004; 14(10):885-90. PMC: 2754830. DOI: 10.1016/j.cub.2004.03.059. View

11.

Ramos F, Chen S, Garelick M, Dai D, Liao C, Schreiber K . Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med. 2012; 4(144):144ra103. PMC: 3613228. DOI: 10.1126/scitranslmed.3003802. View

12.

Robida-Stubbs S, Glover-Cutter K, Lamming D, Mizunuma M, Narasimhan S, Neumann-Haefelin E . TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 2012; 15(5):713-24. PMC: 3348514. DOI: 10.1016/j.cmet.2012.04.007. View

13.

Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

14.

Zid B, Rogers A, Katewa S, Vargas M, Kolipinski M, Lu T . 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell. 2009; 139(1):149-60. PMC: 2759400. DOI: 10.1016/j.cell.2009.07.034. View

15.

Nussenblatt R, Byrnes G, Sen H, Yeh S, Faia L, Meyerle C . A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization. Retina. 2010; 30(10):1579-87. PMC: 3174007. DOI: 10.1097/IAE.0b013e3181e7978e. View

16.

Kaeberlein M, Kennedy B . Protein translation, 2007. Aging Cell. 2007; 6(6):731-4. DOI: 10.1111/j.1474-9726.2007.00341.x. View

17.

Majumder S, Caccamo A, Medina D, Benavides A, Javors M, Kraig E . Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling. Aging Cell. 2012; 11(2):326-35. PMC: 3306461. DOI: 10.1111/j.1474-9726.2011.00791.x. View

18.

Bonawitz N, Chatenay-Lapointe M, Pan Y, Shadel G . Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression. Cell Metab. 2007; 5(4):265-77. PMC: 3460550. DOI: 10.1016/j.cmet.2007.02.009. View

19.

Chen C, Liu Y, Liu Y, Zheng P . mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal. 2009; 2(98):ra75. PMC: 4020596. DOI: 10.1126/scisignal.2000559. View

20.

Curran S, Ruvkun G . Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet. 2007; 3(4):e56. PMC: 1847696. DOI: 10.1371/journal.pgen.0030056. View